{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:32:36Z","timestamp":1787643156541,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40618-021-01648-8","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T16:04:48Z","timestamp":1627920288000},"page":"347-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-4651","authenticated-orcid":false,"given":"R. A. A.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Amr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. N.","family":"Toaima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. H.","family":"Elsedfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"issue":"9477","key":"1648_CR1","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","volume":"365","author":"DP Merke","year":"2005","unstructured":"Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. The Lancet 365(9477):2125\u20132136","journal-title":"The Lancet"},{"key":"1648_CR2","doi-asserted-by":"crossref","first-page":"bcr2015213939","DOI":"10.1136\/bcr-2015-213939","volume":"2016","author":"Y Levy-Shraga","year":"2016","unstructured":"Levy-Shraga Y, Pinhas-Hamiel O (2016) High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia. BMJ Case Rep 2016:bcr2015213939","journal-title":"BMJ Case Rep"},{"issue":"4","key":"1648_CR3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.steroids.2011.12.009","volume":"77","author":"CM Trapp","year":"2012","unstructured":"Trapp CM, Oberfield SE (2012) Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update. Steroids 77(4):342\u2013346","journal-title":"Steroids"},{"issue":"3","key":"1648_CR4","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ENDOCR REV 21(3):245\u2013291","journal-title":"ENDOCR REV"},{"key":"1648_CR5","volume-title":"Genetic steroid disorders","author":"MI New","year":"2013","unstructured":"New MI, Lekarev O, Parsa A, Yuen TT, O\u2019Malley B, Hammer GD (2013) Genetic steroid disorders. Academic Press, London"},{"issue":"12","key":"1648_CR6","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1210\/jc.2002-021732","volume":"88","author":"B Olgem\u00f6ller","year":"2003","unstructured":"Olgem\u00f6ller B, Roscher AA, Liebl B, Fingerhut R (2003) Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab 88(12):5790\u20135794","journal-title":"J Clin Endocrinol Metab"},{"issue":"414","key":"1648_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cca.2012.09.013","volume":"24","author":"S N\u00e9meth","year":"2012","unstructured":"N\u00e9meth S, Riedl S, Kriegsh\u00e4user G, Baumgartner-Parzer S, Concolino P, Neocleous V, Phylactou LA, Borucka-Mankiewicz M, Onay H, Tukun A, Oberkanins C (2012) Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone. Clin Chim Acta 24(414):211\u2013214","journal-title":"Clin Chim Acta"},{"issue":"9","key":"1648_CR8","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.83.9.2841","volume":"83","author":"Y Higashi","year":"1986","unstructured":"Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci 83(9):2841\u20132845","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"1648_CR9","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.83.14.5111","volume":"83","author":"PC White","year":"1986","unstructured":"White PC, New MI, Dupont BO (1986) Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci 83(14):5111\u20135115","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1648_CR10","first-page":"469","volume":"10","author":"MG Forest","year":"2004","unstructured":"Forest MG (2004) Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 10(6):469\u2013485","journal-title":"Hum Reprod"},{"key":"1648_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/494173","volume":"2010","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP et al (2010) A summary of the Endocrine Society clinical practice guidelines on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Int J Pediatr Endocrinol 2010:1\u20135","journal-title":"Int J Pediatr Endocrinol"},{"issue":"2","key":"1648_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/cen.14333","volume":"94","author":"NH Amr","year":"2021","unstructured":"Amr NH, Mahmoud RA, Youssef O, Toaima NN, Elsedfy H (2021) Effect of long-term glucocorticoid therapy on cardiac functions in children with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 94(2):210\u2013218","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1648_CR13","first-page":"231","volume":"9","author":"PA Der","year":"1954","unstructured":"Der PA (1954) Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndroms: Morphologie, Haufigkeit, Entwicklung, und Vererbung der verschiedenen Genitalformen. Helv Paeditr Acta 9:231\u2013248","journal-title":"Helv Paeditr Acta"},{"key":"1648_CR14","unstructured":"OMIM: www.ncbi.nlm.nih.gov\/omim."},{"issue":"2","key":"1648_CR15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","volume":"90","author":"PW Speiser","year":"1992","unstructured":"Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT et al (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90(2):584\u2013595","journal-title":"J Clin Invest"},{"issue":"3","key":"1648_CR16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","volume":"85","author":"N Krone","year":"2000","unstructured":"Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85(3):1059\u20131065","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1648_CR17","first-page":"1145","volume":"78","author":"A Wedell","year":"1994","unstructured":"Wedell A, Thil\u00e9n A, Ritz\u00e9n EM, Stengler B, Luthman H (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78(5):1145\u20131152","journal-title":"J Clin Endocrinol Metab"},{"key":"1648_CR18","first-page":"1","volume":"1","author":"F Elmougy","year":"2020","unstructured":"Elmougy F, Elsharkawy M, Hafez M, Atty SA, Baz H, Ibrahim A et al (2020) Genetic profiling of CAH Egyptian children: rapid guide to clinical interpretation of common mutations. J Clin Invest 1:1\u20131","journal-title":"J Clin Invest"},{"key":"1648_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9040616","author":"RG Al-Obaidi","year":"2016","unstructured":"Al-Obaidi RG, Al-Musawi B, Al-Zubaidi MA, Oberkanins C, N\u00e9meth S, Al-Obaidi YG (2016) Molecular Analysis of CYP21A2 gene mutations among Iraqi patients with congenital adrenal hyperplasia. Enzyme Res. https:\/\/doi.org\/10.1155\/2016\/9040616","journal-title":"Enzyme Res"},{"issue":"3","key":"1648_CR20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4008\/jcrpe.v1i3.49","volume":"1","author":"F Ba\u015f","year":"2009","unstructured":"Ba\u015f F, Kayserili H, Darendeliler F, Uyguner O, G\u00fcn\u00f6z H, Apak MY et al (2009) CYP21A2 gene mutations in congenital adrenal Hyperplasia: genotype\u2212 phenotype correlation in Turkish children. J Clin Res Pediatr Endocrinol 1(3):116","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1648_CR21","doi-asserted-by":"crossref","unstructured":"Daggag H, Hiyesat D, Khawaja N et al (2011) Prevalence of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, in Jordanian sample pool,\u201d in Proceedings of the Endocrine Society\u2019s 93rd Annual Meeting & Expo, National Center for Diabetes Endocrinology and Genetics, Boston, Mass, USA, June 2011.","DOI":"10.1210\/endo-meetings.2011.PART3.P14.P2-739"},{"issue":"2","key":"1648_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/gtmb.2011.0099","volume":"16","author":"B Rabbani","year":"2012","unstructured":"Rabbani B, Mahdieh N, Ashtiani MT, Larijani B, Akbari MT, New M et al (2012) Mutation analysis of the CYP21A2 gene in the Iranian population. Genet Test Mol Biomark 16(2):82\u201390","journal-title":"Genet Test Mol Biomark"},{"issue":"1","key":"1648_CR23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1210\/jc.2003-031056","volume":"89","author":"M Kharrat","year":"2004","unstructured":"Kharrat M, Tardy V, M\u2019Rad R, Maazoul F, Jemaa LB, Refai\u0308 M, Morel Y, Chaabouni H. (2004) Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 89(1):368\u2013374","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1648_CR24","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/jc.2002-021681","volume":"88","author":"NM Stikkelbroeck","year":"2003","unstructured":"Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 88(8):3852\u20133859","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1648_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.2011.04123.x","volume":"75","author":"R Marino","year":"2011","unstructured":"Marino R, Ramirez P, Galeano J, Perez Garrido N, Rocco C, Ciaccio M, Warman DM, Guercio G, Chaler E, Maceiras M, Bergad\u00e1 I (2011) Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype\u2013phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia. Clin Endocrinol 75(4):427\u2013435","journal-title":"Clin Endocrinol"},{"issue":"24","key":"1648_CR26","first-page":"77","volume":"2015","author":"Ishii T, Anzo M, Adachi M, Onigata K, Kusuda S, Nagasaki K. Mass Screening Committee Japanese Society for Pediatric Endocrinology Japanese Society for Mass Screening. Guidelines for diagnosis and treatment of 21-hydroxylase deficiency","year":"2014","unstructured":"Ishii T, Anzo M, Adachi M, Onigata K, Kusuda S, Nagasaki K. Mass Screening Committee Japanese Society for Pediatric Endocrinology Japanese Society for Mass Screening. Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014) revision). Clin Pediatr Endocrinol 2015(24):77\u2013105","journal-title":"Clin Pediatr Endocrinol"},{"issue":"5","key":"1648_CR27","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1002\/mgg3.623","volume":"7","author":"DV Chi","year":"2019","unstructured":"Chi DV, Tran TH, Nguyen DH, Luong LH, Le PT, Ta MH, Ngo HT, Nguyen MP, Le-Anh TP, Nguyen DP, Bui TH (2019) Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia. Mol Genet Genom Med 7(5):e623","journal-title":"Mol Genet Genom Med"},{"issue":"10","key":"1648_CR28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W (2020) EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Euro J Human Genetics 28(10):1341\u20131367","journal-title":"Euro J Human Genetics"},{"issue":"6","key":"1648_CR29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/2359-3997000000119","volume":"59","author":"TMB Rodrigues","year":"2015","unstructured":"Rodrigues TMB, Barra CB, Santos JLS, Goulart EMA, Ferreira AVM, Silva IN et al (2015) Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Arch Endocrinol Metab 59(6):541\u2013547","journal-title":"Arch Endocrinol Metab"},{"key":"1648_CR30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1515\/jpem-2011-0467","volume":"25","author":"MA Abdullah","year":"2012","unstructured":"Abdullah MA, Saeed U, Abass A, Lubna K, Weam A, Ali AS et al (2012) Disorders of sex development among Sudanese children: 5-year experience of a pediatric endocrinology clinic. J Pediatr Endocrinol Metab 25:1065\u20131072","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"1648_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5339\/qmj.2015.11","volume":"2015","author":"LI Alshabab","year":"2015","unstructured":"Alshabab LI, Alebrahem A, Kaddoura A, Al-Fahoum S (2015) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A five-year retrospective study in the Children\u2019s Hospital of Damascus, Syria. Qatar Med J 2015(1):11","journal-title":"Qatar Med J"},{"issue":"1","key":"1648_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0189-6725.48569","volume":"6","author":"OA Sowande","year":"2009","unstructured":"Sowande OA, Adejuyigbe O (2009) Management of ambiguous genitalia in ile ife, Nigeria: challenges and outcome. Afr J Paediatr Surg 6(1):14","journal-title":"Afr J Paediatr Surg"},{"issue":"1","key":"1648_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12887-017-0862-4","volume":"17","author":"J Tony Nengom","year":"2017","unstructured":"Tony Nengom J, Sap Ngo Um S, Chelo D, Mbono Betoko R, Boombhi J, Mouafo Tambo F et al (2017) Assessment of cardiac function in children with congenital adrenal hyperplasia: a case control study in Cameroon. BMC Pediatr 17(1):109","journal-title":"BMC Pediatr"},{"issue":"4","key":"1648_CR34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ymgme.2006.12.005","volume":"90","author":"RC Wilson","year":"2007","unstructured":"Wilson RC, Nimkarn S, Dumic M, Obeid J, Azar M, Najmabadi H, Saffari F, New MI (2007) Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 90(4):414\u2013421","journal-title":"Mol Genet Metab"},{"issue":"8","key":"1648_CR35","first-page":"648","volume":"36","author":"A Bobba","year":"1999","unstructured":"Bobba A, Marra E, Giannattasio S, Iolascon A, Monno F, Di Maio S (1999) 21-hydroxylase deficiency in Italy: a distinct distribution pattern ofCYP21 mutations in a sample from southern Italy. J Med Genet 36(8):648\u2013650","journal-title":"J Med Genet"},{"issue":"2","key":"1648_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/EC-18-0281","volume":"8","author":"S Riedl","year":"2019","unstructured":"Riedl S, R\u00f6hl FW, Bonfig W, Br\u00e4mswig J, Richter-Unruh A, Fricke-Otto S, Bettendorf M, Riepe F, Kriegsh\u00e4user G, Sch\u00f6nau E, Even G (2019) Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients. Endocr Connect 8(2):86\u201394","journal-title":"Endocr Connect"},{"issue":"1","key":"1648_CR37","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","volume":"96","author":"GP Finkielstain","year":"2011","unstructured":"Finkielstain GP, Chen W, Mehta SP, Fujimura FK, Hanna RM, Van Ryzin C et al (2011) Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 96(1):E161\u2013E172","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1648_CR38","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1210\/jcem.85.12.7018","volume":"85","author":"L\u2019allemand D, Tardy V, Gruters A, S","year":"2000","unstructured":"L\u2019allemand D, Tardy V, Gruters A, Schnabel D, Krude H, Morel Y. (2000) How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 85(12):4562\u20134567","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1648_CR39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jc.2008-1174","volume":"94","author":"LG Gomes","year":"2009","unstructured":"Gomes LG, Huang N, Agrawal V, Mendon\u00e7a BB, Bachega TA, Miller WL (2009) Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 94(1):89\u201395","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1648_CR40","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D et al (2013) Genotype\u2013phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci 110(7):2611\u20132616","journal-title":"Proc Natl Acad Sci"},{"issue":"1\u20132","key":"1648_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/07435809509030452","volume":"21","author":"E Schulze","year":"1995","unstructured":"Schulze E, Scharer G, Rogatzki A, Priebe L, Lewicka S, Bettendorf M, Hoepffner W, Heinrich UE, Schwabe U (1995) Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase. Endocr Res 21(1\u20132):359\u2013364","journal-title":"Endocr Res"},{"issue":"11","key":"1648_CR42","first-page":"4081","volume":"81","author":"SF Witchel","year":"1996","unstructured":"Witchel SF, Bhamidipati DK, Hoffman EP, Cohen JB (1996) Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 81(11):4081\u20134088","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1648_CR43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349(8):776\u2013788","journal-title":"N Engl J Med"},{"issue":"5","key":"1648_CR44","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","volume":"94","author":"M Bidet","year":"2009","unstructured":"Bidet M, Bellanne\u0301-Chantelot C, Galand-Portier MB, Tardy V, Billaud L, Laborde K, Coussieu C, Morel Y, Vaury C, Golmard JL, Claustre A. (2009) Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 94(5):1570\u20131578","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1648_CR45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cen.12526","volume":"82","author":"M Barbaro","year":"2015","unstructured":"Barbaro M, Soardi FC, \u00d6stberg LJ, Persson B, de Mello MP, Wedell A, Lajic S (2015) In vitro functional studies of rare CYP 21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 82(1):37\u201344","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1648_CR46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/mend-5-5-685","volume":"5","author":"MT Tusie-Luna","year":"1991","unstructured":"Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC (1991) A mutation (Pro-30 to Leu) in CYP 21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 5(5):685\u2013692","journal-title":"Mol Endocrinol"},{"key":"1648_CR47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fendo.2019.00432","volume":"10","author":"DL Pignatelli","year":"2019","unstructured":"Pignatelli DL, Carvalho BL, Palmeiro A, Barros A, Guerreiro S, Ma\u00e7ut D (2019) The complexities in genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Front Endocrinol 10:432","journal-title":"Front Endocrinol"},{"issue":"1","key":"1648_CR48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.13370","volume":"1402","author":"S Gurgov","year":"2017","unstructured":"Gurgov S, Bernab\u00e9 KJ, Stites J, Cunniff CM, Lin-Su K, Felsen D, New MI, Poppas DP (2017) Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype. Ann N Y Acad 1402(1):56\u201363","journal-title":"Ann N Y Acad"},{"issue":"1","key":"1648_CR49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nyas.13540","volume":"1415","author":"F Elmougy","year":"2018","unstructured":"Elmougy F, Sharaf S, Hafez M, Khattab A, Abou-Yousef H, Elsharkawy M et al (2018) CYP21A2 genetic profile in 14 Egyptian children with suspected congenital adrenal hyperplasia: a diagnostic challenge. Ann N Y Acad 1415(1):11\u201320","journal-title":"Ann N Y Acad"},{"issue":"6","key":"1648_CR50","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2002-021589","volume":"88","author":"SM Baumgartner-Parzer","year":"2003","unstructured":"Baumgartner-Parzer SM, Nowotny P, Waldhausl W, Vierhapper H (2003) A rare duplicated 21-hydroxylase haplotype and a de novo mutation: a family analysis. J Clin Endocrinol Metab 88(6):2794\u20132796","journal-title":"J Clin Endocrinol Metab"},{"key":"1648_CR51","unstructured":"Robins T. Functional and structural studies on CYP21 mutants in congenital adrenal hyperplasia. Institutionen f\u00f6r molekyl\u00e4r medicin\/Department of Molecular Medicine; 2005 Nov 18."},{"key":"1648_CR52","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/ajmg.a.31408","volume":"140","author":"EA Parker","year":"2006","unstructured":"Parker EA, Hovanes K, Germak J, Porter F, Merke DP (2006) Maternal 21-hydroxylase deficiency and uniparental isodisomy of chromosome 6 and X results in a child with 21-hydroxylase deficiency and Klinefelter syndrome. Am J Med Genet A 140:2236\u20132240","journal-title":"Am J Med Genet A"},{"key":"1648_CR53","first-page":"207","volume":"1","author":"RG Khayat","year":"2000","unstructured":"Khayat RG, Saxena PC (2000) Consanguinity and its effect on infant and child mortality in Egypt. Egypt J Med Hum Genet 1:207\u2013213","journal-title":"Egypt J Med Hum Genet"},{"key":"1648_CR54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejmhg.2011.07.001","volume":"12","author":"RM Shawky","year":"2011","unstructured":"Shawky RM, El-Awady MY, Elsayed SM, Hamadan GE (2011) Consanguineous matings among Egyptian population. Egypt J Med Hum Genet 12:157\u2013163","journal-title":"Egypt J Med Hum Genet"},{"issue":"2","key":"1648_CR55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","volume":"23","author":"N Krone","year":"2009","unstructured":"Krone N, Arlt W (2009) Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23(2):181\u2013192","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01648-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T10:24:29Z","timestamp":1642847069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01648-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01648-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"13 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ain Shams University, Egypt, (IRB review number 000017585).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from legal guardians as well as assent from patients\u2009\u2265\u200911\u00a0years.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}